Oil-Free Foaming Acne Wash Facial Cleanser

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This XtraCare acne wash is indicated for the gentle cleansing of existing acne breakouts and for the prevention of future breakouts. It is formulated to penetrate deeply, providing a soothing effect without causing dryness or irritation to the skin. The product rinses clean, ensuring that no residue remains to clog pores.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by wetting the face. Following this, the product should be gently massaged onto the entire face for a duration of 20 to 30 seconds, ensuring that the eye area is avoided. After massaging, it is essential to rinse the face thoroughly with water and then pat dry with a clean towel.

For optimal results, the cleansing process should be performed twice daily.

Contraindications

Use is contraindicated in the following situations:

Swallowing the product is contraindicated; immediate medical assistance or contact with a Poison Control Center is required in such cases. Additionally, contact with the eyes should be avoided; if exposure occurs, it is essential to flush the eyes thoroughly with water.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients that it may cause staining on certain fabrics, and caution should be exercised to prevent contact with such materials.

When this product is used concurrently with other topical acne medications, there is an increased risk of skin dryness or irritation. In such cases, it is recommended that only one medication be used at a time unless otherwise directed by a healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay. Additionally, it is crucial to avoid contact with the eyes. Should contact occur, the affected area must be flushed thoroughly with water to mitigate potential irritation.

Side Effects

Patients should be aware that this product is for external use only. It may cause staining on certain fabrics, which should be considered when applying the product.

In clinical practice, it has been observed that when this product is used concurrently with other topical acne medications or immediately following their application, there may be an increased risk of skin dryness or irritation. In such cases, it is advisable to use only one medication unless otherwise directed by a healthcare professional.

Drug Interactions

Concurrent use of this product with other topical acne medications may lead to an increased risk of skin dryness or irritation. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Oil-Free Foaming Acne Wash Facial Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted. Additionally, care should be taken to avoid contact with the eyes; if contact occurs, the affected area should be flushed thoroughly with water.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for use during pregnancy. Currently, there are no specific warnings or contraindications associated with the use of this product in pregnant patients. Additionally, no dosage modifications are recommended for individuals who are pregnant. There are no special precautions regarding pregnancy mentioned in the prescribing information. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients to avoid contact with their eyes. Should contact occur, they should be directed to flush their eyes thoroughly with water to minimize any potential irritation or harm.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20°C to 25°C (68°F to 77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent exposure to extreme temperatures.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Oil-Free Foaming Acne Wash Facial Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)